Lataa...
Cannabigerol Is a Potential Therapeutic Agent in a Novel Combined Therapy for Glioblastoma
SIMPLE SUMMARY: Among primary brain tumours, glioblastoma is the most aggressive. As early relapses are unavoidable despite standard-of-care treatment, the cannabinoids delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) alone or in combination have been suggested as a combined treatment strate...
Tallennettuna:
| Julkaisussa: | Cells |
|---|---|
| Päätekijät: | , , , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
MDPI
2021
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7914500/ https://ncbi.nlm.nih.gov/pubmed/33562819 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cells10020340 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|